5-[(1S,2S)-1-Hydroxy-2-(4-phenyl-piperidin-1-yl)-propyl]-1,3-dihydro-indol-2-one

ID: ALA366809

PubChem CID: 44383751

Max Phase: Preclinical

Molecular Formula: C22H26N2O2

Molecular Weight: 350.46

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  C[C@@H]([C@@H](O)c1ccc2c(c1)CC(=O)N2)N1CCC(c2ccccc2)CC1

Standard InChI:  InChI=1S/C22H26N2O2/c1-15(22(26)18-7-8-20-19(13-18)14-21(25)23-20)24-11-9-17(10-12-24)16-5-3-2-4-6-16/h2-8,13,15,17,22,26H,9-12,14H2,1H3,(H,23,25)/t15-,22+/m0/s1

Standard InChI Key:  HJRGLUUTXXPQKZ-OYHNWAKOSA-N

Molfile:  

     RDKit          2D

 26 29  0  0  1  0  0  0  0  0999 V2000
   -0.1083   -3.5000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.0792   -2.4542    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4583   -3.0042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4792   -2.7042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4750   -3.3167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5167   -2.7042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5625   -2.6667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0500   -2.4417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0042   -2.4292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0958   -2.5167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0792   -1.8667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6000   -2.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0583   -3.0000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.5125   -3.3292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9917   -3.6125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1167   -1.8792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6042   -1.5667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1167   -2.4667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7167   -1.8792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0417   -1.6542    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5542   -3.3417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7125   -2.4625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2417   -1.5875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7542   -1.8917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2292   -2.7750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7542   -2.4792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  7  1  0
  3  1  1  0
  4  5  2  0
  5  1  1  0
  6 14  1  0
  7  8  1  0
  8  6  1  0
  9  4  1  0
 10  3  1  0
 11  2  1  0
 12  2  1  0
 13  3  2  0
 14 15  2  0
 15  5  1  0
 16 18  1  0
 17 11  1  0
 18 12  1  0
 19 16  1  0
  8 20  1  6
  7 21  1  1
 22 19  2  0
 23 19  1  0
 24 23  2  0
 25 22  1  0
 26 24  1  0
  4 10  1  0
  9  6  2  0
 17 16  1  0
 25 26  2  0
M  END

Associated Targets(non-human)

Grin2c Glutamate [NMDA] receptor subunit epsilon 3 (367 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adra1b Adrenergic receptor alpha-1 (5652 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 350.46Molecular Weight (Monoisotopic): 350.1994AlogP: 3.48#Rotatable Bonds: 4
Polar Surface Area: 52.57Molecular Species: BASEHBA: 3HBD: 2
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 12.18CX Basic pKa: 9.16CX LogP: 3.07CX LogD: 1.31
Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.89Np Likeness Score: -0.36

References

1. Chenard B, Butler T, Shalaby I, Prochniak M, Koe B, Fox C.  (1993)  Oxindole N-Methyl-D-Aspartate (NMDA) antagonists,  (1): [10.1016/S0960-894X(00)80098-0]

Source